2m 2m 2m 2m 2m 2m 2m
ALLOGENE THERAP (ALLO)
NASDAQ
$1.89+$0.005 (+0.27%)
Price as of Aug 03, 2026 10:42 AM EDT- $648.9MMarket Cap
- 74.07%1-Year Change
- BiotechnologyIndustry
ALLOGENE THERAP (ALLO)
$1.89+$0.005 (+0.27%)
Earnings Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -3.65% | ||
12-Month Momentum | 71.54% | ||
3-Month Risk Adjusted Momentum | -14.88% | ||
12-Month Risk Adjusted Momentum | 86.50% |
True Yield
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.0007% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |